Advanced search
Publication Cover
Modern Rheumatology Volume 29, 2019 - Issue 6
Journal homepage
472
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis

New adalimumab formulation associated with less injection site pain and improved motivation for treatment

Tomohiko YoshidaSetagaya Rheumatology Clinic, Tokyo, Japan; ;Rheumatology, Toshin Yoshida Internal Medicine, Nagano, Japan; Correspondence[email protected]
,
Yasuhiro OtakiSetagaya Rheumatology Clinic, Tokyo, Japan; ;General Medical Education and Research Center, Teikyo University, Tokyo, Japan
,
Naooki KatsuyamaSetagaya Rheumatology Clinic, Tokyo, Japan; ;Rheumatology, Toshin Yoshida Internal Medicine, Nagano, Japan;
,
Michiko SekiSetagaya Rheumatology Clinic, Tokyo, Japan;
&
Junko KubotaRheumatology, Toshin Yoshida Internal Medicine, Nagano, Japan;
Pages 949-953 | Received 01 Nov 2017, Accepted 03 Sep 2018, Published online: 29 May 2019

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Christopher J. Rini, Bruce C. Roberts, Aishwarya Vaidyanathan, Aojun Li, Rick Klug, Douglas B. Sherman & Ronald J. Pettis. (2022) Enabling faster subcutaneous delivery of larger volume, high viscosity fluids. Expert Opinion on Drug Delivery 19:9, pages 1165-1176.
Read now
Hai-Lin Liu, Rui-Hao Zhou, Li-Li Luo, Xue Yuan, Ling Ye & He-Guo Luo. (2020) Ultrasound-Guided Transversus Abdominis Plane Block for Cesarean Delivery: Injection Site Pain as a New Complication and Dexamethasone Reduced Incidence. Journal of Pain Research 13, pages 565-573.
Read now

Articles from other publishers (11)

Sophia Junker, Oliver Ebert & Robert Bartsch. (2023) A Systematic Literature Review of Injection Site Pain Perception in Adult Patients Treated with Citrate-Free and Citrate-Containing Biologic Agents. Current Rheumatology Reviews 19:3, pages 303-313.
Crossref
Yingnan Shen, Sameep Rajubhai Shah, Kejie Zhao & Bumsoo Han. (2023) Experimental and computational analysis of the injection-induced mechanical changes in the skin microenvironment during subcutaneous injection of biologics. Extreme Mechanics Letters 61, pages 102025.
Crossref
Debra Ignaut, Tsuyoshi Fukuda, Ramanjineyulu Bandi, Marcel Ermer, Marc S. Stoffel, Eric Zijlstra & Chad Paavola. (2022) An Investigation Into Local Infusion Site Pain After Infusion of Ultra Rapid Lispro Excipients Across Sites and Depths. Journal of Diabetes Science and Technology, pages 193229682211352.
Crossref
Bita Taghizadeh, Mahmoud Reza Jaafari & Nosratollah Zarghami. (2022) New insight into the importance of formulation variables on parenteral growth hormone preparations: potential effect on the injection-site pain. Frontiers in Endocrinology 13.
Crossref
Sanjay Chabra, B. J. Gill, Gaia Gallo, Danting Zhu, Celine Pitou, Christopher D. Payne, Ana Accioly & Luis Puig. (2022) Ixekizumab Citrate-Free Formulation: Results from Two Clinical Trials. Advances in Therapy 39:6, pages 2862-2872.
Crossref
Maria Lambros, Thac (Henry) Tran, Qinqin Fei & Mike Nicolaou. (2022) Citric Acid: A Multifunctional Pharmaceutical Excipient. Pharmaceutics 14:5, pages 972.
Crossref
Enrico Fusaro, Patrick Durez, Johannes Wohlrab, Soohyun Lee, SangWook Yoon & Hubert Marotte. (2022) An update on the adalimumab biosimilar landscape following approval of the first high-concentration biosimilar. Immunotherapy 14:3, pages 235-252.
Crossref
Ombretta Viapiana, Soohyun Lee, SangWook Yoon & Bruno Fautrel. (2022) Stepping Forward to the Next Level: Totality of Evidence for the First High-Concentration Adalimumab Biosimilar, CT-P17. Clinical Drug Investigation 42:2, pages 103-112.
Crossref
Steven R. Feldman, Nataliya Reznichenko, Grazyna Pulka, Külli Kingo, George Galdava, Fausto Berti, Joanna Sobierska, Roshan Dias, Eric Guenzi, Hendrik Otto, Halimu N. Haliduola, Richard Kay & Heimo Stroissnig. (2021) Efficacy, Safety and Immunogenicity of AVT02 Versus Originator Adalimumab in Subjects with Moderate to Severe Chronic Plaque Psoriasis: A Multicentre, Double-Blind, Randomised, Parallel Group, Active Control, Phase III Study. BioDrugs 35:6, pages 735-748.
Crossref
Manfred Gross & Birgit Terjung. (2021) Neues zu COVID-19, Kolon & CED vom europäischen Gastroenterologie-Kongress. Gastro-News 8:3, pages 56-61.
Crossref
. (2020) Ueg Week 2020 Poster Presentations . United European Gastroenterology Journal 8:S8, pages 144-887.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.